1.
Ahasan MH, Mahmood M, Adhikary DK, Ahsan SA, Ahmed CM, Salim MA, Ahmed K, Amin MR, Khaled MFI, Singha CK, Islam R, Ansari S, Biswas SK, Karna R, Banerjee SK. Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital. Univ. Heart J. [Internet]. 2022 Jan. 31 [cited 2022 Aug. 15];18(1):10-3. Available from: https://banglajol.info/index.php/UHJ/article/view/57874